Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs.

Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs.

HSV-2 vaccine is needed to prevent genital disease, latent infection, and virus transmission. A replication-deficient mutant virus (dl5-29) has demonstrated promising efficacy in animal models of genital herpes. However, the immunogenicity, protective efficacy, and non-replicative status of the high...

Full description

Bibliographic Details
Main Authors: Marie-Clotilde Bernard, Véronique Barban, Fabrine Pradezynski, Aymeric de Montfort, Robert Ryall, Catherine Caillet, Patricia Londono-Hayes
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4383384?pdf=render

Internet

http://europepmc.org/articles/PMC4383384?pdf=render

Similar Items